What Is the Difference Between PLS and ALS?
At a Glance
Primary Lateral Sclerosis (PLS) affects only upper motor neurons, causing muscle stiffness, and progresses much more slowly than classic ALS. Classic ALS attacks both upper and lower motor neurons, leading to rapid muscle wasting and weakness.
In this answer
5 sections
Hearing that you might have Primary Lateral Sclerosis (PLS) or Progressive Muscular Atrophy (PMA) means that your condition behaves differently from classic Amyotrophic Lateral Sclerosis (ALS) [1]. While classic ALS involves the rapid degeneration of both upper and lower motor neurons [2][3], PLS and PMA are considered “restricted variants” on the ALS spectrum [4][5]. This distinction is critical because patients with these variants typically experience a slower disease progression and have a longer life expectancy than those with classic ALS [6][1].
Understanding Upper vs. Lower Motor Neurons
To understand the difference between these conditions, it helps to know how your brain talks to your muscles. This happens through a two-step relay system:
- Upper motor neurons: These are the nerve cells in your brain that send the initial command down your spinal cord. When they degenerate, your muscles become tight, stiff, and overactive—a condition called spasticity [7].
- Lower motor neurons: These nerve cells pick up the signal in the spinal cord and carry it directly to your muscles. When they break down, the muscles lose their nerve connection entirely, leading to severe weakness, twitching, and shrinking, which is known as atrophy [8].
Classic ALS attacks both sets of neurons simultaneously [2].
What is Primary Lateral Sclerosis (PLS)?
PLS is a condition that primarily attacks only the upper motor neurons [4]. For someone diagnosed with PLS, this means the main symptoms are severe stiffness, clumsiness, and balance issues, rather than rapid muscle wasting [7]. PLS usually starts in the legs, making walking feel stiff or “heavy,” though it can sometimes begin by affecting the muscles used for speech [7].
The most encouraging difference for patients with pure PLS is the prognosis. PLS progresses much more slowly than classic ALS [6]. Unlike ALS, pure PLS generally spares the muscles needed for breathing, and the need for a feeding tube or breathing support is very rare [7]. Many people with PLS maintain their independence for a long time and have a much longer survival rate compared to classic ALS [6][7].
What is Progressive Muscular Atrophy (PMA)?
PMA represents the other end of the motor neuron disease spectrum. It primarily attacks the lower motor neurons [8][9]. Patients with PMA experience profound muscle weakness, shrinking, and twitching, but do not have the stiff, spastic muscles seen in PLS or classic ALS [8].
Like PLS, PMA is often considered a variant of ALS that generally progresses more slowly than the classic disease [9]. However, researchers have found that the underlying cellular changes in PMA are very similar to those in ALS [9][10]. While PMA progresses slower than classic ALS, it often has a less favorable prognosis than PLS. Over time, the disease can spread to involve the muscles used for breathing and swallowing, meaning respiratory support may eventually be necessary [6].
Why the Diagnosis Can Take Time
It is common for a neurologist to diagnose “suspected” PLS or PMA and then monitor your symptoms for years before confirming it. Distinguishing early PLS from a slow-moving form of ALS can be incredibly difficult during the first few years [5][11]. This is because some patients who initially show only upper motor neuron signs (like in PLS) or only lower motor neuron signs (like in PMA) will eventually develop the other symptoms, revealing that they actually have classic ALS [7][8].
Because of this overlap, neurologists usually require that a patient show isolated upper motor neuron symptoms for 3 to 4 years before officially confirming a “definite” PLS diagnosis [7]. During this waiting period, your care team will monitor you closely using physical exams and nerve tests (EMGs) [7].
It is important to report any new “red flag” symptoms between appointments. If you were diagnosed with suspected PLS due to stiffness, contact your doctor if you start experiencing muscle twitching or rapid weakness [7]. If you were diagnosed with PMA, let your doctor know if you develop significant muscle stiffness or severe cramps [8].
Managing Symptoms While You Wait
Waiting for a definitive diagnosis can take an immense psychological toll, but you do not have to wait to start managing your symptoms. Even without a confirmed diagnosis, your care team can prescribe targeted treatments to improve your daily quality of life [7].
- Medications: Muscle relaxers can help ease the painful spasticity and cramping associated with upper motor neuron involvement [7].
- Physical and Occupational Therapy: Therapists can provide safe stretching routines to maintain joint flexibility, recommend supportive devices for walking, and help you conserve your energy [7].
- Support Groups: The uncertainty of a suspected motor neuron disease diagnosis can be isolating and paralyzing. Connecting with support groups or seeking psychological counseling can be incredibly beneficial for navigating this limbo [7].
Common questions in this guide
What is the main difference between PLS and ALS?
Is Progressive Muscular Atrophy (PMA) the same as ALS?
Why does it take so long to get a confirmed PLS diagnosis?
Can I get treatment while waiting for a definitive diagnosis?
What new symptoms should I report to my doctor while being monitored?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What specific changes or new symptoms should I report to you immediately during this waiting period?
- 2.Based on my current symptoms, would I benefit from visiting a multidisciplinary ALS clinic now, even without a confirmed diagnosis?
- 3.How often will I need repeat EMGs or nerve tests to monitor my condition?
- 4.What physical therapy or exercise routines are safe and beneficial for my current symptoms?
- 5.What medications are available right now to help manage my muscle stiffness, cramping, or twitching?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (11)
- 1
Familial clustering of primary lateral sclerosis and amyotrophic lateral sclerosis: Supplementary evidence for a continuum.
Corcia P, Lunetta C, Couratier P, et al.
European journal of neurology 2021; (28(8)):2780-2783 doi:10.1111/ene.14960.
PMID: 34110677 - 2
History of ALS and the competing theories on pathogenesis: IFCN handbook chapter.
Eisen A, Vucic S, Mitsumoto H
Clinical neurophysiology practice 2024; (9()):1-12 doi:10.1016/j.cnp.2023.11.004.
PMID: 38213309 - 3
Lower and upper motor neuron involvement and their impact on disease prognosis in amyotrophic lateral sclerosis.
Zakharova MN, Abramova AA
Neural regeneration research 2022; (17(1)):65-73 doi:10.4103/1673-5374.314289.
PMID: 34100429 - 4
The clinical spectrum of primary lateral sclerosis.
Barohn RJ, Fink JK, Heiman-Patterson T, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2020; (21(sup1)):3-10 doi:10.1080/21678421.2020.1837178.
PMID: 33602013 - 5
Primary lateral sclerosis: diagnosis and management.
Turner MR, Talbot K
Practical neurology 2020; (20(4)):262-269 doi:10.1136/practneurol-2019-002300.
PMID: 32217663 - 6
The Benign Course of PLS: A Strong Point in Favor of an Earlier Differentiation From ALS.
Agosta F, Filippi M
Neurology 2021; (96(17)):783-784 doi:10.1212/WNL.0000000000011773.
PMID: 33637628 - 7
Primary lateral sclerosis: consensus diagnostic criteria.
Turner MR, Barohn RJ, Corcia P, et al.
Journal of neurology, neurosurgery, and psychiatry 2020; (91(4)):373-377 doi:10.1136/jnnp-2019-322541.
PMID: 32029539 - 8
Progressive Muscular Atrophy.
Liewluck T, Saperstein DS
Neurologic clinics 2015; (33(4)):761-73.
PMID: 26515620 - 9
Adult-onset spinal muscular atrophy: An update.
Juntas Morales R, Pageot N, Taieb G, Camu W
Revue neurologique 2017; (173(5)):308-319 doi:10.1016/j.neurol.2017.03.015.
PMID: 28456383 - 10
Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.
Saberi S, Stauffer JE, Schulte DJ, Ravits J
Neurologic clinics 2015; (33(4)):855-76.
PMID: 26515626 - 11
The diagnostic challenge of primary lateral sclerosis: the integration of clinical, genetic and radiological cues.
Bede P, Siah WF
European journal of neurology 2021; (28(12)):3875-3876 doi:10.1111/ene.15049.
PMID: 34339556
This page explains the differences between motor neuron diseases for educational purposes only. Always consult your neurologist for an accurate diagnosis, monitoring, and treatment plan for your specific symptoms.
Get notified when new evidence is published on Amyotrophic lateral sclerosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.